<<
macrobiotic diet
palliative care
macrocytosis
Down syndrome
macrogol
macrolides
clinical pharmacology
macule (definition)
magnesium
drug-induced arrhythmias
formulations
magnesium antacid
magnesium aspartate
magnesium chloride
magnesium hydroxide
magnesium sulfate
magnesium supplements
hypomagnesaemia
palliative care (table)
magnesium antacid
magnesium aspartate
magnesium chloride
magnesium hydroxide
magnesium imbalance
common causes (table)
hypermagnesaemia
hypomagnesaemia
magnesium replacment
drug-induced arrhythmias
magnesium salts
magnesium sulfate
magnesium supplements
magnesium+aluminium hydroxide
magnetic field therapy
palliative care
magnetic resonance imaging
epilepsy
headache
cough exertional or sexual
exertional or sexual)
headache (cough
exertional or sexual)
lumbosacral plexitis
multiple sclerosis
stroke
children
maintenance intravenous fluids (table)
major depressive disorder
adjustment disorder with depressed and/or anxious mood
assessment
assessment considerations (box)
bipolar depression
changing antidepressants
antidepressant-free intervals (table)
children
diagnosis
nonpharmacological treatment
pharmacological treatment
other antidepressants
selective serotonin reuptake inhibitors
suicidal ideation and behaviour
dysthymic disorder
electroconvulsive therapy
major depression
perinatal depression
recurrent depression
suicidal patients
risk factors (box)
suicide risk assessment (box)
treatment
nonpharmacological
pharmacological
antidepressant discontinuation
concurrent anxiolytic or hypnotic
failure to respond
first-line therapy
general considerations
second-line therapy
principles
major trauma
abdominal injuries
chest injuries
head injuries
Makaton vocabulary
Unaided augmentative and alternative communication systems: developmental disability
Prader-Willi syndrome: biopsychosocial issues
malabsorption
bacterial overgrowth
chronic pancreatitis
coeliac disease
Crohn's disease
cystic fibrosis
short bowel syndrome
vitamin deficiency
malaria
G6PD deficiency
prophylaxis
stand-by treatment
treatment
Plasmodium falciparum
severe
uncomplicated
Plasmodium malariae
Plasmodium ovale
Plasmodium vivax
vector avoidance
Malassezia yeasts
pityriasis versicolor
seborrhoeic dermatitis
malathion (maldison)
Maldison index page
Toxicology: organophosphates
maldison
male infertility
antirheumatic drugs
male sexual dysfunction
malignancy (see also cancer)
childhood (palliative care)
malignant middle cerebral artery infarction
malignant multiple sclerosis
malignant otitis externa
malingering
Mallampati score (figure)
procedural sedation record
MALT lymphoma
Indications to test for and treat H. pylori infection (Table 6.4)
H. pylori and gastric cancer
mandibular advancement splints
mania (acute)
developmental disability
treatment
behavioural disturbance (oral)
behavioural disturbance (parenteral)
continuation
failure to respond
pathologically elevated mood
principles
manic depressive illness
acute treatment
behavioural disturbance (oral)
behavioural disturbance (parenteral)
continuation
failure to respond
pathologically elevated mood
principles for acute mania
bipolar depression
treatment
failure to respond
pharmacological
principles
children (juvenile)
Juvenile bipolar disorder
Bipolar disorder: general information
dysphoric mania
general information
mixed episodes
prophylactic treatment
key interventions
broad treatment program
co-morbidity management
family/carer involvement
physical health management
pharmacological
psychological
rapid cycling
manipulation
neck pain
acute
chronic
palliative care
mannitol
Mantoux test
tuberculosis latent infection
manual therapies
Manuka honey
MAOIs
adverse effects
frequency (table)
breastfeeding
changing antidepressants
antidepressant-free intervals (table)
clinical pharmacology
dietary guidelines (table)
interactions
pharmacokinetics properties (table)
pregnancy
Marburg virus
marijuana
therapeutic use
spasticity (multiple sclerosis)
spasticity (palliative care)
marine envenoming
clinical features of stings or injuries (table)
first aid and treatment
geographical distribution in Australia (table)
marine poisoning
mask ventilation
masquerades (developmental disability)
massage
low back pain
palliative care
Complementary and alternative medicines
Domicillary palliative care: what is available to meet the needs?
general pain
muscle pain
post-traumatic headache
tension headache
massive transfusion
mastalgia
cyclical pain
noncyclical pain
mastitis
mastoiditis
otitis media
masturbation (developmental disability)
anal
excessive
privacy
maternal serum screening
developmental disability
maturity onset diabetes of the young (MODY)
Classification of diabetes
Maturity onset diabetes of the young
mauve stinger (table)
McDonald criteria
definition
diagnosis of multiple sclerosis
McMurray's test
MDI (metered dose inhaler)
MDI (multiple daily injections of insulin)
adults
children
MDMA (ecstasy)
general information
overdose and toxicity
poisoning
amphetamines
serotonin toxicity (table)
mebendazole
mebeverine
mechanical syndromes
spinal pain
medial branch blocks
medial epicondylitis
characteristics
management
medial tibial stress syndrome
medical emergencies
dental surgery
drugs and equipment required
types
allergies
anaphylactic and anaphylactoid reactions
cardiovascular
endocrine
neurological
respiratory
dermatological
generalised pustular psoriasis
staphylococcal scalded skin syndrome
palliative care
airways obstruction (acute)
haemorrhage
spinal cord compression
superior vena cava obstruction
medication review
developmental disability
adolescents
aged care
epilepsy
preventive health care
Health screening in people with developmental disability
Preventive health care and health promotion in people with developmental disability: medication review
medication-induced disorders
gastrointestinal
constipation (box)
diarrhoea
diarrhoea (box)
liver disease
nausea and vomiting
Drug-induced nausea and vomiting
Identifying patients at risk of PONV
NSAID-induced ulcers
oesophageal injury
pancreatitis (table)
haematological
folate deficiency
neurological
akathisia
chorea
dystonia
headache
movement disorders
parkinsonism
skin reactions
medication-overuse headache
medications
ceasing in terminal phase
Addison's disease
diabetes
hypercholesterolaemia
hypertension
psychological effects
Intercurrent illnesses and palliative care
Burden of disease in patients receiving palliative care
thyroid disease
children
drugs (and doses) commonly used in paediatric palliative care (table)
dental management of patients taking
impaired swallowing
practical issues related to domiciliary care
meditation
pain management
medium-chain triglycerides
medroxyprogesterone acetate
mefenamic acid
Nonsteroidal anti-inflammatory drugs (NSAIDs) index page
Mefenamic acid index page
mefloquine
megaloblastic anaemia
megestrol acetate
meibomian abscess
melaena
melanocytic naevi
giant
pigmented birthmarks
melanoma
diagnosis (box)
management
excision margins (box)
palliative care
risk factors (skin check box)
types
acral lentiginous
desmoplastic
lentigo maligna
nail apparatus
nodular
superficial spreading
warning signs (box)
melasma
melatonin
melioidosis
biological warfare
systemic infection
meloxicam
melphalan
adverse effects
interstitial lung disease
memantine
men's health
developmental disability
Health screening in people with developmental disability
Men's health (developmental disability)
androgen deficiency
diagnosis
symptoms
treatment
cryptorchidism
testicular surveillance
delayed puberty
ejaculatory failure
erectile dysfunction
inguinal hernia
prostate cancer
screening
symptoms
menarche
developmental disability
Down syndrome: secondary school (12 to 18 years)
Women's health (developmental disability): menarche and onset of puberty
Meniere's disease
recurrent vertigo
meningitis
corticosteroids
directed therapy
cryptococcal
Haemophilus influenzae type b
Listeria monocytogenes
Neisseria meningitidis (meningococcal)
Streptococcus agalactiae
Streptococcus pneumoniae
empirical therapy
health care-associated
home-based therapy
immediate and early hospital management
management algorithm
neonates and infants
prophylaxis
Haemophilus influenzae type b
Neisseria meningitidis (meningococcus)
meningococcaemia (acute)
meningococcal meningitis
meningococcal sepsis
meningococcus
conjunctivitis
meningitis
Neisseria meningitidis (meningococcal meningitis)
Meningitis: introduction
severe sepsis
meniscal cysts
menopause
developmental disability
Women's health (developmental disability): menopause
Down syndrome: adulthood
menorrhagia
acute emergency
anovulatory
developmental disability
ovulation-associated
menstruation
amenorrhoea
primary
secondary
developmental disability
management
Down syndrome: secondary school (12 to 18 years)
Symptoms more common in people with developmental disability: inability to cope with menstruation
Management of an adolescent with developmental disability: checklist of issues to be addressed in adolescence (Table 11.8)
Women's health (developmental disability): menstrual management
problems
suppression
dysmenorrhoea
menorrhagia
acute emergency
anovulatory
ovulation-associated
treatment (table)
migraine
normal menstrual cycle
physiology (figure)
polycystic ovary syndrome (PCOS)
premenstrual syndrome (PMS)
mental health
developmental disability
adolescents
Management of an adolescent with developmental disability: medical issues
Management of an adolescent with developmental disability: checklist of issues to be addressed in adolescence (Table 11.8)
adults
cerebral palsy
Down syndrome
menthol
meperidine
mephalan
mepivacaine
mercaptopurine
mercury poisoning (table)
meropenem
mesalazine
mesna
mesothelioma
mestranol
metabolic adverse effects
antipsychotic drugs
Antipsychotic drugs: adverse effects
Treatment of schizophrenia: management of antipsychotic adverse effects
metabolic storage disorder
palliative care
metapneumovirus (human)
bronchiolitis
metaraminol
metastases
bone (palliative care)
skin (palliative care)
metatarsalgia
metered dose inhalers
breath-activated inhaler
patient information (box)
common errors in use
technique
patient information (box)
with spacer
without spacer
use and cleaning
metformin
methadone
methaemoglobinaemia
articaine
causative agents
clinical effects (table)
prilocaine
treatment
methamphetamine
abuse
breastfeeding
overdose and toxicity
pregnancy
methanol
poisoning
immediate antidote treatment
paediatric poisoning (table)
methicillin
clinical pharmacology
methicillin-resistant Staphylococcus aureus (MRSA)
community associated/acquired
boils and carbuncles
scalded skin syndrome
severe sepsis
community-associated
endocarditis
cystic fibrosis
endocarditis
impetigo
osteomyelitis
prostheses-related
peritonitis complicating CAPD
recurrent skin infection
severe sepsis
febrile neutropenia
surgical prophylaxis
endoscopic procedures
vancomycin monitoring
VISA
surgical prophylaxis
wound infections (postoperative)
methotrexate
methoxsalen
methoxyflurane
methyl salicylate
methyldopa
methylene blue
methylenedioxymethamphetamine (ecstasy)
general information
overdose and toxicity
methylphenidate
methylprednisolone
methylprednisolone aceponate
methysergide
metoclopramide
metoprolol
metronidazole
metyrapone
mexiletine
mianserin
miconazole
microdermabrasion
aged and photoaged face
pigmentary irregularity
wrinkles
microscopic polyangiitis
diagnosis
features
investigations
prognosis
treatment
Microscopic polyangiitis
Treatment regimens for systemic vasculitis (polyarteritis nodosa, microscopic polyangiitis, Wegener's granulomatosis)
induction of remission
maintenance
microsporidia
Microsporum canis
tinea
scalp (tinea capitis)
microvascular decompression
hemifacial spasm
trigeminal neuralgia
midazolam
midodrine
migraine
acute attack
first-line treatment
general considerations
precautions with treatment
second-line treatment
treatment of nausea and vomiting
aura without headache
breastfeeding
children
classical
common
facial
hormone replacement therapy
lactation
menstrual
oral contraceptives
persistent
pregnancy
prophylaxis
nonpharmacological
pharmacological
resistant
stroke risk
vertigo
Recurrent vertigo: introduction
Migrainous vertigo
with aura
without aura
migrainous vertigo
milestones developmental (developmental disability)
milia
definition (milium)
miliaria
miliary tuberculosis
milk and milk products
calcium content
lactose content
Miller Fisher variant
milrinone
Milrinone index page
Milrinone index page
mineral deficiency
palliative care
vitamin and mineral deficiencies (table)
mineralocorticoids
clinical pharmacology
Mini-mental State Examination (MMSE)
developmental disability
minimum volume resuscitation
ectopic pregnancy
minocycline
minoxidil
mirtazapine
miscarriage
abortifacients
complementary and alternative medicines
systemic lupus erythematosus
misoprostol
mite bites
mitotane
mitoxantrone
mitozantrone
mixed connective disease
features
prognosis
treatment
mixed insulin regimen
type 1 diabetes
adults
children
type 2 diabetes
adults
MMSE (Mini-mental State Examination)
developmental disability
mobilisation
neck pain
acute
chronic
sprains and strains
mobility (developmental disability)
Constipation in adults with developmental disability: introduction
Aged care in people with developmental disability: osteoporosis, falls and fractures
Management of an adolescent with developmental disability: checklist of issues to be addressed in adolescence (Table 11.8)
Mobiluncus species
bacterial vaginosis
moclobemide
modafinil
models of disability
modified-release preparations
analgesic drugs
modulation of pain
MODY (maturity onset diabetes of the young)
Classification of diabetes
Maturity onset diabetes of the young
Mohs' surgery
basal cell carcinoma
intraepidermal carcinoma
moisturisers
clinical pharmacology
therapeutic use
atopic eruption of pregnancy
cholestasis of pregnancy
dermatitis
atopic
contact
Grover's disease
ichthyosis vulgaris
itch without rash
lichenoid drug eruptions
pityriasis alba
pompholyx
psoriasis
rosacea
scabies (post-treatment itch)
types and properties (table)
moles
molluscum contagiosum
mometasone
monitoring
antiepileptic drugs
biochemical
haematological
plasma concentrations
toxicity
biochemical parameters
antipsychotic drugs
carbamazepine
clozapine
lithium
mianserin
sodium valproate
drug blood levels
aminoglycosides
antiepileptic drugs
beta lactams
carbamazepine
Acute mania: primary treatment of pathologically elevated mood
Prophylaxis for bipolar disorder: pharmacological treatment
clozapine
endocarditis
flucytosine
itraconazole
lamotrigine
lithium
Acute mania: primary treatment of pathologically elevated mood
Prophylaxis for bipolar disorder: pharmacological treatment
phenytoin
psychotropic drugs
sodium valproate
Acute mania: primary treatment of pathologically elevated mood
Prophylaxis for bipolar disorder: pharmacological treatment
teicoplanin
vancomycin
monoamine oxidase inhibitors irreversible nonselective (see also individual drugs)
adverse effects
frequency (table)
breastfeeding
changing antidepressants
antidepressant-free intervals (table)
clinical pharmacology
dietary guidelines (table)
interactions
pharmacokinetics properties (table)
poisoning
pregnancy
monoarthritis
blood tests
causes
diagnostic clues (box)
joint aspiration
radiological examination
treatment
when to refer
monobactams
mononeuropathy
mononucleosis (infectious)
monosodium urate deposition disease
asymptomatic hyperuricaemia
characteristics
chronic tophaceous gout
clinical presentation
acute
asymptomatic hyperuricaemia
chronic
subacute
diagnostic workup
drugs affecting
hyperuricaemia prevalence
kidney
chronic urate nephropathy
nephrolithiasis
management
acute
chronic
general considerations
intercritical
pathogenesis
uric acid metabolism
montelukast sodium
mood disorders
bipolar disorder
depression
Depression
Depression: introduction
fragile X syndrome
grief
mixed mood episodes (developmental disability)
mood disturbances
palliative care
depression
euphoria and elation
mood stabilisers (see also individual drugs)
bipolar disorder
acute treatment
developmental disability
prophylaxis
drugs for bipolar disorder
antiepileptics
lithium
fragile X syndrome
Moraxella catarrhalis
bronchiectasis
COPD (acute exacerbations)
otitis media
rhinosinusitis (acute bacterial)
morbilliform (definition)
morning after pill
morphine
morphoea
Morton's neuroma
motility stimulants
motion sickness
prophylaxis
treatment
motion-induced vertigo
benign paroxysmal positional
vestibular lesion (uncompensated)
motor dysfunction
palliative care
Parkinson's disease
motor neurone disease
palliative care
mould
asthma trigger (table)
mouth care
developmental disability
Health screening in people with developmental disability
Commonly unrecognised or untreated conditions in adults with developmental disability
Oral health in people with developmental disability
cerebral palsy
Cerebral palsy: dental health
Cerebral palsy: management of associated health problems
dental caries
dental erosion
dental malocclusion
Down syndrome
dysphagia
Dysphagia in people with developmental disability: management
Oral health in people with developmental disability
periodontal disease
Prader-Willi syndrome
saliva control
palliative care
mouthwashes (see also individual agents)
use of alcohol in
movement disorders
chorea
drug-induced
dystonias
drug-induced
focal
generalised
hemifacial spasm
hyperkinetic
hypokinetic
myoclonus
palliative care
Parkinson plus disorders
corticobasal ganglionic degeneration
multiple system atrophy
progressive supranuclear palsy
Parkinson's disease
prevalence (table)
symptoms
tardive syndromes
tics
tremor
essential
isolated
orthostatic
task-specific
moxifloxacin
moxonidine
MRI (magnetic resonance imaging)
epilepsy
headache (cough
exertional or sexual)
lumbosacral plexitis
multiple sclerosis
stroke
children
MRSA
community associated/acquired
boils and carbuncles
endocarditis
scalded skin syndrome
severe sepsis
community-associated
endocarditis
severe sepsis
cystic fibrosis
endocarditis
impetigo
osteomyelitis
prostheses-related
peritonitis complicating CAPD
recurrent skin infection
severe sepsis
febrile neutropenia
surgical prophylaxis
endoscopic procedures
vancomycin monitoring
VISA
surgical prophylaxis
wound infections (postoperative)
mucolytics
clinical pharmacology
therapeutic use
bronchiectasis
chronic obstructive pulmonary disease (COPD)
cystic fibrosis
mucopolysaccaride storage disorders (developmental disability)
mucosa-associated lymphoid tissue lymphoma
Indications to test for and treat H. pylori infection (Table 6.4)
H. pylori and gastric cancer
mucosal disease
angular cheilitis
candidosis
discolourations
erythema multiforme
fungal infections
geographic tongue
hairy tongue
lichen planus
mucositis
mucous membrane pemphigoid
oral hairy leukoplakia
pemphigus vulgaris
ulcers
mucositis
AIDS
management
palliative care
mucous membrane pemphigoid
photo
mulga snake bite
antivenom treatment
coagulopathy type (table)
envenoming effects (table)
multidimensional approach to chronic pain
multifocal motor neuropathy with conduction block
multimodal analgesia
definition
perioperative pain
multimodal communication (developmental disability)
multiple chemical sensitivity
multiple daily injections of insulin (MDI)
adults
children
multiple injuries
pain management
multiple sclerosis
anaesthetics
breastfeeding
Devic's disease
diagnosis
diet
Multiple sclerosis: general advice
Multiple sclerosis: therapy directed at symptoms
genetic risk
hormone replacement therapy
immunisation
monitoring
oral contraceptives
palliative care
pregnancy
relapses
acute
mild
moderate
severe
smoking
substance abuse
support groups
surgery
symptoms
Symptoms of multiple sclerosis (Box 7.3)
Multiple sclerosis: introduction
bladder
bowel
fatigue
neurological
psychiatric
sexual difficulties
spasticity
tremor
trigeminal neuralgia
therapy
immunomodulators
immunosuppressants
monitoring
nonresponders
underlying disease
travel
trigeminal neuralgia
types
Types of multiple sclerosis (Table 7.12)
Multiple sclerosis: introduction
benign
malignant
primary progressive
relapsing progressive
relapsing-remitting
secondary progressive
table
multiple system atrophy
prevalence
treatment
multisystem failure
palliative care
multitrauma patients
assessment (box)
pain management
mupirocin
muscle cramps
muscle diseases
acquired myopathies
dermatomyositis
inclusion body myositis
muscular dystrophies
polymyositis
muscle paralysis
neuromuscular blocking agents
rapid sequence induction
therapeutic hypothermia
muscle relaxants
muscle relaxation
pain management
muscle spasm
nonsurgical postoperative pain
muscular dystrophy
palliative care
musculoskeletal disorders
dental issues in patients with
developmental disability
cerebral palsy
Cerebral palsy: management of associated health problems
Cerebral palsy: musculoskeletal effects
palliative care
bone metastases
cramps and spasms
myoclonus
myopathies and myasthenias
restless legs syndrome
rheumatology guidelines
mushroom workers' lung
mushrooms
poisoning
myasthenia
palliative care
myasthenia gravis
diagnosis
ocular
thymectomy
treatment
mycobacterial infections
M. abscessus
M. avium complex
cervical lymphadenitis
disseminated
Mycobacterium avium complex (MAC): introduction
Disseminated Mycobacterium avium complex (MAC)
pulmonary
Mycobacterium avium complex (MAC): introduction
Pulmonary Mycobacterium avium complex (MAC)
M. chelonae
M. fortuitum
M. kansasii
M. leprae
M. marinum
M. tuberculosis
M. ulcerans
Mycobacterium abscessus
Mycobacterium avium complex (MAC)
cervical lymphadenitis
disseminated
opportunistic infection (HIV)
pulmonary
Mycobacterium avium complex (MAC): introduction
Pulmonary Mycobacterium avium complex (MAC)
bronchiectasis aetiology
classification
hot tub lung
treatment
daily regimen
three times weekly regimen
Mycobacterium chelonae
Mycobacterium fortuitum
Mycobacterium kansasii
Mycobacterium leprae
Mycobacterium marinum
Mycobacterium tuberculosis
cervical lymphadenitis
opportunistic infection (HIV)
respiratory pathogens associated with immunodeficiency (table)
tuberculosis
Mycobacterium ulcerans
mycophenolate mofetil
Mycoplasma species
acute bronchitis
M. genitalium
pelvic inflammatory disease
urethritis
M. hominis
severe sepsis
vaginosis
pneumonia
Community-acquired pneumonia in adults: introduction
Community-acquired pneumonia in adults: risk classes I and II
Specific therapy for other pathogens causing bacterial pneumonia (Table 2.16)
children
parapneumonic effusion and empyema
myectomy
myeloma
respiratory pathogens
myocardial infarction
6-month risk of death or MI with ACS-like chest pain (table)
complications following MI
arrhythmias
cardiogenic shock
left ventricular failure
pericarditis
persistent or recurrent pain
right ventricular infarction
dental treatment issues in patients with
emergency
management (box)
non-ST elevation acute coronary syndromes (NSTEACS)
features (box)
features associated high-
intermediate-
& low-risk NSTEACS (box)
high-risk patients
intermediate-risk patients
low-risk patients
ST elevation infarction (STEMI)
complications following MI
immediate and early hospital management
reperfusion therapy
fibrinolytic therapy
adjuvant antithrombin therapy
contraindications to (box)
haemorrhage and fibrinolytic therapy
indications for reperfusion therapy (box)
percutaneous coronary intervention (PCI)
subsequent management of STEMI
ACE inhibitors
dosing regimens for (table)
aldosterone antagonists
angiotensin II receptor blockers
anticoagulants
antiplatelet therapy
beta blockers
calcium channel blockers
statins
myocardial ischaemia
initial emergency management (flowchart)
myoclonic seizures
definition
myoclonus
definition
movement disorders
palliative care
myopathies
acquired
palliative care
myotonia
myotoxicity
myxoedema
pretibial
myxoedema coma
myxoid pseudocyst
>>